Apart some paperwork that still remains to be completed, no barriers exist for the Russia’s Sputnik V COVID-19 vaccine to be registered after all the barriers have been cleared with the World Health Organization (WHO), Russian Health Minister Mikhail Murashko stressed on Saturday as quoted by Asharq al Awsat.
Sputnik V vaccine, widely used in Russia and approved in more than 70 countries, is undergoing review process in the WHO and the European Medicines Agency (EMA. If approved, new markets could open up for the Russian jab, especially in Europe.
After meeting with the WHO director-general Tedros Adhanom Ghebreyesus in Geneva, Murashko noted that the company dealing with Sputnik V registration at WHO has only few more documents to sign and to submit a few additional papers since Russia’s position on promotion and registration of the vaccine is already presented.
The WHO said in July that its review of Sputnik V vaccine’s production in Russia had shown some issues with the filling of vials at one plant which were addressed since by the manufacturer.
While waiting for the WHO and EMA’s approval, Russia started discussions with the US in Geneva on Saturday on the mutual recognition of COVID-19 vaccination certificates.
Russian Health Minister noted that their American colleagues have realized the rationality behind this since they’re talking about recognition of certificates, not vaccines and pointed there’s a difference between approving the vaccine for sale on the market and approving the jab for direct prevention of the COVID-19 disease.
As The Washington Post previously reported, US authorities may not permit entry for the foreigners inoculated with Sputnik V vaccine starting in November when they’ll be required to show proof of complete vaccination against COVID-19.
The article added they’ll have to be inoculated with US or the WHO’s approved jabs.